Nicotinamide increases systemic vascular resistance in ovine endotoxemia

Intensive Care Medicine

Volumn 29, Issue 6, 2003, Pages 989-994

  Scharte, Marion ^a   Nofer, Jerzy Roch ^a   Van Aken, Hugo ^a   Waurick, Rene ^a   Meyer, Jörg ^a   Bone, Hans Georg ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Endotoxin; Inflammation; Liver injury; PARP; Sheep; Vasoconstriction

Indexed keywords

ENDOTOXIN; GAMMA GLUTAMYLTRANSFERASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ARGININE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG EFFECT; DRUG INFUSION; ENDOTOXEMIA; ENERGY; ENZYME ACTIVATION; FEMALE; HEART INDEX; HEMODYNAMIC MONITORING; HYPOTHESIS; INFLAMMATION; LIVER FUNCTION; LIVER INJURY; NONHUMAN; PROSPECTIVE STUDY; PROTEIN FUNCTION; SALMONELLA TYPHI; SHEEP; SYSTEMIC VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0037490099     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1738-7     Document Type: Article

References (32)

1. Szabo C, Zingarelli B, O'Connor M, Salzman AL (1996) DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93:1753-1758
2. Berger NA (1991) Oxidant-induced cytotoxicity: a challenge for metabolic modulation. Am J Respir Cell Mol Biol 4:1-3
3. Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-Ribose) polymerase inhibitors. Pharmacol Rev 54:375-429
4. Morris SM Jr, Billiar TR (1994) New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:E829-839
5. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624
6. Zhang J, Dawson VL, Dawson TM, Snyder SH (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687-689
7. Szabo C, Zingarelli B, Salzman AL (1996) Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 78:1051-1063
8. Zingarelli B, O'Connor M, Wong H, Salzman AL, Szabo C (1996) Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 156:350-358
9. Zingarelli B, Salzman AL, Szabo C (1996) Protective effects of nicotinamide against nitric oxide-mediated delayed vascular failure in endotoxic shock: potential involvement of polyADP ribosyl synthetase. Shock 5:258-264
10. Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL (1997) Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100:723-735
11. Szabo C (1998) Potential role of the peroxynitrate-poly(ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock 9:341-344
12. Szabo A, Hake P, Salzman AL, Szabo C (1998) 3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock. Shock 10:347-353
13. Goldfarb RD, Marton A, Szabo E, Virag L, Salzman AL, Glock D, Akhter I, McCarthy R, Parrillo JE, Szabo C (2002) Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 30:974-980
14. 2 exchange and energy metabolism during hyperdynamic porcine endotoxemia. Intensive Care Med 27:586-592
15. Allman KG, Stoddart AP, Kennedy MM, Young JD (1996) L-arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia. Am J Physiol 271:H1296-1301
16. Szabo C (1998) Role of poly(ADP-ribose)synthetase in inflammation. Eur J Pharmacol 350:1-19
17. Banasik M, Komura H, Shimoyama M, Ueda K (1992) Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP- ribosyl)transferase. J Biol Chem 267:1569-1575
18. Liaudet L, Szabo E, Timashpolsky L, Virag L, Cziraki A, Szabo C (2001) Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br J Pharmacol 133:1424-1430
19. LeDoux SP, Hall CR, Forbes PM, Patton NJ, Wilson GL (1988) Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity. Diabetes 37:1015-1019
20. Wray GM, Hinds CJ, Thiemermann C (1998) Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin. Shock 10:13-19
21. Osman J, Jablon S, Parrillo NR, Easington CR, Parrillo JE, Hollenberg SM (1998) Poly-ADP ribosyl synthetase inhibition reverses vascular hyporeactivity in septic mice. Crit Care Med 26[Suppl]:A134
22. Hauschildt S, Scheipers P, Bessler WG, Mulsch A (1992) Induction of nitric oxide synthase in L929 cells by tumour-necrosis factor alpha is prevented by inhibitors of poly(ADP-ribose) polymerase. Biochem J 288:255-600
23. Le Page C, Sanceau J, Drapier JC, Wietzerbin J (1998) Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem Biophys Res Commun 243:451-457
24. Pellat-Deceunyk K, Wietzerbin J, Drapier JC (1994) Nicotinamide inhibits nitric oxide sythase mRNA induction in activated macrophages. Biochem J 297:53-58
25. Szabo C, Wong HR, Bauer PI, Kirsten E, O'Connor M, Zingarelli B, Mendeleyev J, Hasko G, Vizi ES, Salzman AL, Kun E (1997) Regulation of components of the inflammatory response by 5-iodo-6-amino-1,2-benzopyrone, and inhibitor of poly(ADP-ribose)synthetase and pleiotropic modifier of cellular signal pathways. Int J Oncol 10:1093-1101
26. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. Embo J 18:4446-4454
27. Soriano FG, Liaudet L, Szabo E, Virag L, Mabley JG, Pacher P, Szabo C (2002) Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 17:286-292
28. Holme JA, Soderlund EJ, Brunborg G, Lag M, Nelson SD, Dybing E (1991) DNA damage and cell death induced by 1,2-dibromo-3-chloropropane (DBCP) and structural analogs in monolayer culture of rat hepatocytes: 3-aminobenzamide inhibits the toxicity of DBCP. Cell Biol Toxicol 7:413-432
29. Kroger H, Ehrlich W, Klewer M, Gratz R, Dietrich A, Miesel R (1996) The influence of antagonists of poly(ADP-ribose) metabolism on acetaminophen hepatotoxicity. Gen Pharmacol 27:167-170
30. Szabo C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ, Salzman AL, Perretti M (1997) Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med 186:1041-1049
31. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabo C (1998) Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP- ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharmacol 342:67-76
32. Yamamoto K, Tsukidate K, Farber JL (1993) Differing effects of the inhibition of poly(ADP-ribose) polymerase on the course of oxidative cell injury in hepatocytes and fibroblasts. Biochem Pharmacol 46:483-491